Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial

التفاصيل البيبلوغرافية
العنوان:	Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial
المؤلفون:	Udwadia, Zarir F., Singh, Pawan, Barkate, Hanmant, Patil, Saiprasad, Rangwala, Shabbir, Pendse, Amol, Kadam, Jatin, Wu, Wen, Caracta, Cynthia F., Tandon, Monika
المصدر:	In International Journal of Infectious Diseases February 2021 103:62-71
قاعدة البيانات:	ScienceDirect

الوصف
تدمد:	12019712
DOI:	10.1016/j.ijid.2020.11.142